Xana, Smart Neurostimulation

Xana, Smart Neurostimulation

Xana develops smart-non-invasive neurostimulation systems to treat neurological diseases.

Xana is a neurotechnological company founded in 2016 in Switzerland. They are developing smart & non-invasive neurostimulation systems to treat neurological conditions.

XANA's pipeline covers several medical indications such as insomnia, migraine, stroke, heart failure, tinnitus, and depression. Their focus on non-invasive treatments is aligned with the growing demand for effective yet non-intrusive medical interventions. The company operates within the Health Care, Health and Wellness, and Medical Devices industries.

While information regarding Xana's last investment and the involved investors is currently unavailable, the company's innovative approach to addressing neurological conditions through smart neurostimulation systems presents a potentially promising investment opportunity within the burgeoning field of neurotechnology and medical devices.